The number of GNAO1-encephalopathy cases increases steadily since 2013, and it is clear that this rare neurological disease currently suffers from underdiagnosis due to the inaccessibility of whole-genome/exome or even targeted sequencing to many pediatric centers worldwide. This evidence concerns the gene GNAO1 and Encephalopathy.